22 results on '"Rohr, Irena"'
Search Results
2. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study
3. Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study
4. Human papillomavirus prevalence in pregnant women living with human immunodeficiency virus infection: a scoping review of the literature.
5. Human papillomavirus prevalence in pregnant women living with human immunodeficiency virus infection: a scoping review of the literature
6. 8 Senkungszustände des weiblichen Genitale und Harninkontinenz
7. Prenatal ultrasound screening and pregnancy outcomes in HIV-positive women in Germany: Results from a retrospective single-center study at the Charité-Universitätsmedizin Berlin.
8. Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV)
9. 8 Senkungszustände des weiblichen Genitale und Harninkontinenz
10. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study
11. 2022-RA-991-ESGO Assessment of high-risk human papillomavirus infections and cervical dysplasia in human immunodeficiency virus-positive pregnant women in germany: a prospective cross-sectional two-center study
12. Imaging of placental transport mechanisms: A review
13. Inanspruchnahme von Gesundheitsleistungen und Versorgungsqualität aus Perspektive der Eltern - Ergebnisse der multizentrischen, prospektiven Beobachtungsstudie ICON zur juvenilen idiopathischen Arthritis
14. Predictive and prognostic clinical and molecular markers for primary epithelial ovarian cancer
15. Symptom burden and outcomes in patients with platinum resistant/ refractory (PRR) and potentially platinum sensitive ROC receiving ≥ 3 lines of chemotherapy (PPS ≥3) – The Gynecologic Cancer Intergroup (GCIG) Symptom Benefit Study (SBS)
16. What are the expectations and preferences of patients with ovarian cancer to a maintenance therapy? A NOGGO/GCIG/ENGOT-ov22 survey (Expression IV) in 2101 patients.
17. Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC)
18. The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients—results from the OVCAD study
19. The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study.
20. Peritoneal and upper genital tract tuberculosis.
21. The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study.
22. Role of IGF-I in Primary Ovarian Cancer - A Study of the OVCAD European Consortium.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.